What is the Success Rate of Spravato
Spravato (Esketamine) has shown promising results for patients with treatment-resistant depression, offering hope when traditional antidepressants haven’t worked. Clinical studies report significant improvement in symptoms for many patients, especially when combined with ongoing therapy. At MDDCare, we connect you with authentic Spravato clinics across the USA, helping you access advanced, FDA-approved care tailored to your needs.